Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does recHDL Given i.v. Before CEA Prevent Cerebral Ischaemia? - the Reveal Study.

NCT00822302 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.

NCT NCT00822302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00822302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does recHDL Given i.v. Before CEA Prevent Cerebral Ischaemia? - the Reveal Study.
Lead sponsor
St George's, University of London
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2006
Completion date
February 28, 2009
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke